| RS2127643852 |
FARS2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS2127643855 |
FARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS2127651823 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127653183 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127663896 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS2127664245 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127664665 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127665867 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127665958 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2127665995 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2127666004 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2127666049 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127666072 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127666093 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127667021 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127667058 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127667162 |
LCA5
|
Health Risk |
Likely pathogenic |
— |
| RS2127669254 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127679847 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127679884 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2127680021 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS2127680039 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127680192 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127680222 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127680289 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127682146 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127682999 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS2127683029 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS2127683593 |
PHIP
|
Health Risk |
Pathogenic |
Schizophrenia, Schizophrenia |
| RS2127686639 |
POLR1C
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 3, Treacher Collins syndrome 3 |
| RS2127689099 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Hereditary sensory and autonomic neuropathy type 6 |
| RS2127690980 |
PHIP
|
Health Risk |
Pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127691140 |
POLR1C
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 11, Treacher Collins syndrome 3 |
| RS2127691868 |
PHIP
|
Health Risk |
Pathogenic |
See cases, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127698054 |
ELOVL4
|
Health Risk |
Likely pathogenic |
Spastic ataxia, Spastic ataxia |
| RS2127698493 |
ELOVL4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2127698518 |
ELOVL4
|
Health Risk |
Pathogenic |
— |
| RS2127698531 |
ELOVL4
|
Health Risk |
Pathogenic |
— |
| RS2127698713 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS2127698743 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2127698980 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2127701393 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127703554 |
ELOVL4
|
Health Risk |
Likely pathogenic |
— |
| RS2127705231 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127714980 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127718540 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127718655 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127718679 |
FARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS2127721830 |
PHIP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2127726114 |
BCKDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2127726128 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2127726212 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2127727907 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2127727924 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2127735189 |
JARID2
|
Health Risk |
Pathogenic |
Mild intellectual disability, Mild intellectual disability |
| RS2127740492 |
PHIP
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2127740526 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127740900 |
PHIP
|
Health Risk |
Likely pathogenic |
— |
| RS2127741566 |
PHIP
|
Health Risk |
Pathogenic/Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related disorder |
| RS2127741611 |
PHIP
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2127743491 |
JARID2
|
Health Risk |
Pathogenic |
— |
| RS2127748476 |
PHIP
|
Health Risk |
Pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127749078 |
TUBB
|
Health Risk |
Likely pathogenic |
Multiple benign circumferential skin creases on limbs 1, Complex cortical dysplasia with other brain malformations 6 |
| RS2127749124 |
TUBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Complex cortical dysplasia with other brain malformations 6, Complex cortical dysplasia with other brain malformations 6 |
| RS2127749712 |
TUBB
|
Health Risk |
Likely pathogenic |
— |
| RS2127749740 |
TUBB
|
Health Risk |
Likely pathogenic |
Complex cortical dysplasia with other brain malformations 6, Complex cortical dysplasia with other brain malformations 6 |
| RS2127749786 |
TUBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormal brain morphology, Inborn genetic diseases |
| RS2127749978 |
TUBB
|
Health Risk |
Likely pathogenic |
Ventriculomegaly, Hypoplasia of the corpus callosum |
| RS2127756207 |
JARID2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Developmental delay with variable intellectual disability and dysmorphic facies |
| RS2127756209 |
JARID2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2127760440 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127767937 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127767975 |
FARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS2127768101 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2127768716 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127768828 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2127769312 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS2127773120 |
POLH
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS2127773185 |
POLH
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS2127775550 |
BCKDHB
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS2127779345 |
BCKDHB
|
Health Risk |
Likely pathogenic |
— |
| RS2127781697 |
FLT4
|
Health Risk |
Likely pathogenic |
— |
| RS2127784434 |
DTNBP1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 7, Hermansky-Pudlak syndrome 7 |
| RS2127785060 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS2127787560 |
FLT4
|
Health Risk |
Likely pathogenic |
FLT4-related disorder, FLT4-related disorder |
| RS2127802292 |
FLT4
|
Health Risk |
Likely pathogenic |
— |
| RS2127821940 |
POLH
|
Health Risk |
Likely pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS2127830414 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Hereditary sensory and autonomic neuropathy type 6 |
| RS2127838700 |
GTPBP2
|
Health Risk |
Likely pathogenic |
Jaberi-Elahi syndrome, Jaberi-Elahi syndrome |
| RS2127839096 |
FLT4
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS2127840239 |
GTPBP2
|
Health Risk |
Pathogenic |
Jaberi-Elahi syndrome, Jaberi-Elahi syndrome |
| RS2127840543 |
ZNF292
|
Health Risk |
Likely pathogenic |
— |
| RS2127859550 |
ZNF292
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2127859619 |
ZNF292
|
Health Risk |
Likely pathogenic |
— |
| RS2127862686 |
ZNF292
|
Health Risk |
Likely pathogenic |
Motor delay, Intellectual developmental disorder |
| RS2127862824 |
ZNF292
|
Health Risk |
Likely pathogenic |
— |
| RS2127863644 |
ZNF292
|
Health Risk |
Pathogenic |
— |
| RS2127864363 |
ZNF292
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 64 |
| RS2127867376 |
ZNF292
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2127867444 |
ZNF292
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 64 |